Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
Medtronic
Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Details for Patent: 4,786,505

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 4,786,505
Title: Pharmaceutical preparation for oral use
Abstract:Pharmaceutical preparation containing omeprazole together with an alkaline reacting compound or an alkaline salt of omeprazole optionally together with an alkaline compound as the core material, one or more subcoating layers comprising inert reacting compounds which are soluble or rapidly disintegrating in water, or polymeric, water soluble filmforming compounds, optionally containing pH-buffering alkaline compounds and an enteric coating as well as a process for the preparation thereof and the use in the treatment of gastrointestinal diseases.
Inventor(s): Lovgren; Kurt I. (Molnlycke, SE), Pilbrant; Ake G. (Kungsbacka, SE), Yasumura; Mitsuru (Hyogo, JP), Morigaki; Satoshi (Hyogo, JP), Oda; Minoru (Ohita, JP), Ohishi; Naohiro (Fukuoka, JP)
Assignee: Aktiebolaget Hassle (SE)
Application Number:07/040,491
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,786,505
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use; Process;

Drugs Protected by US Patent 4,786,505

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,786,505

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8610572Apr 30, 1986

International Family Members for US Patent 4,786,505

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 240250   Start Trial
Austria 140387   Start Trial
Austria 184482   Start Trial
Austria 84215   Start Trial
Australia 601974   Start Trial
Australia 7191287   Start Trial
Canada 1292693   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
Johnson and Johnson
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.